ALS

DEER PARK, Ill. — September 28, 2026 Eton Pharmaceuticals, Inc. announced the U.S. commercial launch of IMPAVIDO® (miltefosine) capsules,...

BOSTON, Mass. — September 28, 2026 Tiziana Life Sciences, Ltd. announced that the first three participants have been dosed...

New York, U.S., September 22, 2026 Envisagenics and Boehringer Ingelheim have entered a multi-year research collaboration and option agreement...

Bengaluru, Karnataka, India, September 21, 2026 Biocon Biologics Limited, a wholly owned subsidiary of Biocon Limited, has reached a...

Carlsbad, California, U.S., September 22, 2026 Ionis Pharmaceuticals, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...

TEL AVIV, Israel, Aug. 31, 2026 NeuroSense Therapeutics Ltd. announced an accelerated and capital-efficient development strategy for PrimeC, its...

Houston, Texas, Aug 27, 2026 Cellenkos, Inc. has received FDA Fast Track designation for CK0803, an investigational allogeneic, cord...

Worcester, Massachusetts, August 17, 2026 Leal Therapeutics, a clinical-stage biopharmaceutical company developing neuro-metabolic therapeutics for central nervous system disorders,...

SALT LAKE CITY, Utah, August 10, 2026 Clene Inc. announced new biomarker analyses for CNM-Au8 that will be included...

CAMBRIDGE, Mass., August 6, 2026 Amylyx Pharmaceuticals reported its second quarter 2026 financial results, highlighting significant progress across its...